Key facts
- Notable investors include Bailey Biofund, Darwin Venture Management.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Protuoso Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Protuoso Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Protuoso Biosciences
Developer of multifunctional biologic therapeutics designed to address complex diseases with unmet medical needs. The company offers a protein engineering platform using computational protein design and synthetic biology to discover and develop therapeutic candidates, enabling pharmaceutical researchers and biotechnology organizations to study and advance biologic drug development.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Website
- protuoso.bio/
- Ownership
- Privately Held (backing)
Protuoso Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Protuoso Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Protuoso Biosciences in its N-PORT filings yet. We sweep new filings monthly.